| Alyssa Emily Beck, MD | |
|
200 W Arbor Dr, San Diego, CA 92103-9000 | |
| (800) 926-8273 | |
| Not Available |
| Full Name | Alyssa Emily Beck |
|---|---|
| Gender | Female |
| Speciality | Hematology/oncology |
| Experience | 7 Years |
| Location | 200 W Arbor Dr, San Diego, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346771425 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | A163080 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Uc San Diego Health Hillcrest - Hillcrest Med Ctr | San diego, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Regents Of The University Of California | 3577476761 | 1692 |
News Archive
Combination therapy with the PD-L1 inhibitor atezolizumab and the VEGF inhibitor bevacizumab significantly improves overall survival and progression-free survival in patients with unresectable hepatocellular carcinoma compared to standard of care, showed results from a phase 3 study reported at the ESMO Asia 2019 Congress.
Speaking as Scotland's politicians prepared to debate the final stages of a smoking ban, the leader of Scotland's doctors congratulated Ministers for their commitment to the public health agenda. In his address to the Annual Conference of the BMA in Manchester today (Wednesday 29 June 2005), Dr Peter Terry, chairman of the BMA in Scotland said:
An estimated 200,000 high school students who are bullied bring weapons to school, according to research to be presented Sunday, May 4, at the Pediatric Academic Societies (PAS) annual meeting in Vancouver, British Columbia, Canada.
Emergent BioSolutions today announced positive results from a Phase II clinical study evaluating a new simplified dosing regimen for the company's next generation single dose oral typhoid vaccine. The results of the study were published in the August edition of the Journal of Infectious Diseases.
Today, the American College of Physicians and AARP launched an online guide to help inform consumers about the health care law. The guide is written and organized in a way that clearly explains what the law has changed, why these changes were made and when the changes will take effect.
› Verified 4 days ago
| Entity Name | Regents Of The University Of California |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376646869 PECOS PAC ID: 3577476761 Enrollment ID: O20031112000695 |
News Archive
Combination therapy with the PD-L1 inhibitor atezolizumab and the VEGF inhibitor bevacizumab significantly improves overall survival and progression-free survival in patients with unresectable hepatocellular carcinoma compared to standard of care, showed results from a phase 3 study reported at the ESMO Asia 2019 Congress.
Speaking as Scotland's politicians prepared to debate the final stages of a smoking ban, the leader of Scotland's doctors congratulated Ministers for their commitment to the public health agenda. In his address to the Annual Conference of the BMA in Manchester today (Wednesday 29 June 2005), Dr Peter Terry, chairman of the BMA in Scotland said:
An estimated 200,000 high school students who are bullied bring weapons to school, according to research to be presented Sunday, May 4, at the Pediatric Academic Societies (PAS) annual meeting in Vancouver, British Columbia, Canada.
Emergent BioSolutions today announced positive results from a Phase II clinical study evaluating a new simplified dosing regimen for the company's next generation single dose oral typhoid vaccine. The results of the study were published in the August edition of the Journal of Infectious Diseases.
Today, the American College of Physicians and AARP launched an online guide to help inform consumers about the health care law. The guide is written and organized in a way that clearly explains what the law has changed, why these changes were made and when the changes will take effect.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Alyssa Emily Beck, MD Po Box 232410, San Diego, CA 92193-2410 Ph: () - | Alyssa Emily Beck, MD 200 W Arbor Dr, San Diego, CA 92103-9000 Ph: (800) 926-8273 |
News Archive
Combination therapy with the PD-L1 inhibitor atezolizumab and the VEGF inhibitor bevacizumab significantly improves overall survival and progression-free survival in patients with unresectable hepatocellular carcinoma compared to standard of care, showed results from a phase 3 study reported at the ESMO Asia 2019 Congress.
Speaking as Scotland's politicians prepared to debate the final stages of a smoking ban, the leader of Scotland's doctors congratulated Ministers for their commitment to the public health agenda. In his address to the Annual Conference of the BMA in Manchester today (Wednesday 29 June 2005), Dr Peter Terry, chairman of the BMA in Scotland said:
An estimated 200,000 high school students who are bullied bring weapons to school, according to research to be presented Sunday, May 4, at the Pediatric Academic Societies (PAS) annual meeting in Vancouver, British Columbia, Canada.
Emergent BioSolutions today announced positive results from a Phase II clinical study evaluating a new simplified dosing regimen for the company's next generation single dose oral typhoid vaccine. The results of the study were published in the August edition of the Journal of Infectious Diseases.
Today, the American College of Physicians and AARP launched an online guide to help inform consumers about the health care law. The guide is written and organized in a way that clearly explains what the law has changed, why these changes were made and when the changes will take effect.
› Verified 4 days ago
Dr. Ramin Motarjemi, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 200 W Arbor Dr, San Diego, CA 92103 Phone: 858-249-2500 Fax: 858-657-8069 | |
Dr. Shweta Warner, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 4647 Zion Ave, San Diego, CA 92120 Phone: 619-221-6258 Fax: 619-221-6012 | |
Dr. Matthew James Roosevelt, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 4647 Zion Ave, Department Of Hospital Medicine, San Diego, CA 92120 Phone: 619-952-5091 | |
Dr. Daniel Joseph Desantis, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: Naval Medical Ctr, 34800 Bob Wilson Dr., San Diego, CA 92134 Phone: 619-532-7935 | |
Kris Kumar, Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 200 W Arbor Dr, San Diego, CA 92103 Phone: 800-926-8273 Fax: 888-539-8781 | |
Jedidiah Daniel Bell, Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 200 W Arbor Dr, San Diego, CA 92103 Phone: 619-471-0434 | |
Dr. Umber Dube, MD PHD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 8899 University Center Lane, Suite 350 Mc 0975, San Diego, CA 92122 Phone: 858-657-1675 |